A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight

NCT04184622 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2539

Enrollment

INDUSTRY

Sponsor class

Conditions

Overweight
Obesity

Interventions

DRUG: Tirzepatide
DRUG: Placebo

Sponsor

Eli Lilly and Company